News | News By Subject | News by Disease News By Date | Search News

Epilepsy News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Pfizer (PFE) Fined a Record $107 Million for Ramping Up Epilepsy Drug Price by as Much as 2,600%     12/7/2016
UCB Soars Most Since 2009 After US District Court Backs Epilepsy Drug Vimpat Patent     8/15/2016
10,000+ Women Took Sanofi (SNY)'s Anti-Epilepsy Drug Despite Risk to Fetuses     8/10/2016
GW Pharma (GWPH)’s Epidiolex Meets Primary Endpoint in Phase III     6/27/2016
In Light of Disappointing Trial Results, Acorda (ACOR) Terminates Epilepsy Drug Program     5/20/2016
GW Pharma (GWPH) Shares Double as Cannabis Drug Meets Goals in Phase III Study     3/15/2016
Christmas Comes Early to SAGE Therapeutics (SAGE) Investors as Company Accelerates Promising Pipeline Timeline     12/17/2015
FDA Seeks More Information on Zogenix (ZGNX)'s Phase III Study of ZX008     10/20/2015
Sun Pharma Group Stocks Dip on U.S. FDA Denial for its Epilepsy Drug     9/28/2015
Watchdog Accuses Pfizer (PFE) of Overcharging By Millions for Epilepsy Drug     8/6/2015
Zogenix (ZGNX) and FDA Delay Two Rare Epilepsy Trials by Three Months     7/15/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
MA Startup SAGE Therapeutics' Drug For Rare Epilepsy Shows Promise In Small Study     11/10/2014

News from Around the Web
GW Pharma (GWPH) Is Set To Benefit As Cannabis Takes On Cancer     2/10/2017
France Launches Fund to Help Sanofi (SNY) Epilepsy Drug Victims     11/16/2016
Implant Halts Seizures, Memorial Healthcare System Study     10/12/2016
Marijuana-Based Drug Helps Kids With Rare Forms Of Epilepsy In Studies, GW Pharma (GWPH) Reveals     6/28/2016
Links Between Autism And Epilepsy Deepen, Karolinska Institute Study     6/16/2016
Heart Rate Variability Predicts Epileptic Seizure, Kumamoto University Study     4/4/2016
Type 1 Diabetes Linked To Epilepsy Risk, China Medical University Children's Hospital Study     4/1/2016
Changes In Heart Activity May Signal Epilepsy, Case Western Reserve University Study     3/10/2016
Wristband Detects And Alerts For Seizures, Monitors Stress, MIT Study     3/10/2016
Realizing The Promise Of Neuromodulation     3/4/2016
Smartwatch App Detects Epileptic Seizures And Texts A Warning     1/8/2016
Virtual Brain Surgery Could Personalise Epilepsy Treatment, Newcastle University Study     12/16/2015
New Personal Monitoring Devices For Epilepsy May Offer Alternatives To Inpatient Video EEG, University of Utah Study     12/7/2015
Viva Vagus: Wandering Nerve Could Lead To Range Of Therapies     11/16/2015
Record Epileptic Seizures With An Apple Watch, Johns Hopkins University School of Medicine Reveals     10/16/2015

Press Releases
American Academy of Neurology Release: Seizures Tracked With Apple Watch App Linked To Stress, Missed Sleep     2/22/2017
Knopp Biosciences Announces NIH Blueprint Grant Award For Advancing Novel Neonatal Epilepsy Treatments     2/16/2017
INSYS Announces Use Of Cannabidiol Oral Solution For Compassionate Use Studies In Patients Completing Long-Term Safety Study     2/15/2017
Marinus Pharma (MRNS) Release: Ganaxolone Reduces Seizures And Improves Behaviors in Angelman Syndrome Preclinical Model     2/14/2017
MMJ PhytoTech Phase ll Clinical Trial For Treatment of Epilepsy Underway     2/13/2017
Medtronic (MDT) Release: First Procedure Performed In Company MRI-Guided Laser Ablation Trial To Treat Common Form Of Epilepsy     1/24/2017
UCB Release: Company Files BRIVIACT (Brivaracetam) CV In The U.S. As Monotherapy Treatment For Adult Epilepsy Patients With Partial-Onset Seizures     1/20/2017
Adamas Pharma (ADMS) Completes Phase I Clinical Trial Of ADS-4101 For Treatment Of Partial Onset Seizures In Patients With Epilepsy     1/4/2017
Neurelis Intranasal Diazepam Treatment For Epilepsy Granted Fast Track Designation By FDA     1/4/2017
Eisai Inc. (ESALF.PK) Announces Final Results From Phase 3 Open-Label Study Of Rufinamide At American Epilepsy Society Annual Meeting     12/6/2016
Eisai Inc. (ESALF.PK) Announces New Analyses And Data On Perampanel At American Epilepsy Society Meeting     12/6/2016
Zynerba (ZYNE) Reports Positive Results For ZYN002 CBD Gel In Phase I Studies At 70th Annual Meeting Of The American Epilepsy Society     12/5/2016
Pairnomix Presents Systematic Approach To Identifying Approved Drugs That May Be Repurposed For Treatment Of Rare Genetic Diseases     12/5/2016
Evogen And UCB Announce Collaboration For Further Development Of EvoScore START For Improved Diagnosis Of Epilepsy     12/5/2016
Evogen Studies Presented At 2016 American Epilepsy Society Annual Meeting Highlight Importance Of Improved Diagnostic Tools For Epilepsy     12/5/2016

//-->